In the study, measurement of serum CYFRA 21-1 emerged as a valuable substitute biomarker for tumor advancement, particularly in instances where Tg remains undetectable or unmonitored due to the presence of Tg antibodies (TgAb) or in poorly differentiated thyroid carcinoma. The gene discussed is TG; the disease is poorly differentiated thyroid gland carcinoma.